NCT02673814 Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer Status WITHDRAWN Phase PHASE2
NCT02669914 MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors Status TERMINATED Phase PHASE2
NCT02664935 National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT02664181 Rational EpigenetiC Immunotherapy for SEcond Line Therapy in Patients With NSCLC: PRECISE Trial Status COMPLETED Phase PHASE2
NCT02663492 Transcutaneous Electrical Acupoint Stimulation for Non-small Cell Lung Cancer Patients Status UNKNOWN Phase NA
NCT02658890 An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread Status COMPLETED Phase PHASE1/PHASE2
NCT02658747 Neutropenic Sepsis in Patients With Non-Small Cell Lung Cancer Treated With Single-Agent Docetaxel and Associated Resource Use in the UK Status COMPLETED Phase N/A
NCT02657434 A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132) Status COMPLETED Phase PHASE3
NCT02651506 Electromagnetic Navigational Bronchoscopy Vs. Transthoracic Needle Biopsy for the Sampling of Peripheral Lung Nodules Status WITHDRAWN Phase PHASE2
NCT02651441 D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC) Status UNKNOWN Phase PHASE1/PHASE2
NCT02646020 Aprepitant vs. Desloratadine in EGFR-TKIs Related Pruritus Treatment Status COMPLETED Phase PHASE2
NCT02644889 EGFR Mutation Detection From Advanced NSCLC Patient Tissue and Plasma in EGFR-TKI Treatment Status UNKNOWN Phase N/A
NCT02643407 Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer Status UNKNOWN Phase PHASE3
NCT02638090 Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02630186 A Phase 1b/2 Study of Safety and Efficacy of Rociletinib in Combination With MPDL3280A in Patients With Advanced or Metastatic EGFR-mutant NSCLC Status TERMINATED Phase PHASE1/PHASE2
NCT02620657 Evaluate EGFR Mutation Status and Impact Factors in North China Status COMPLETED Phase N/A
NCT02619448 Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC Status RECRUITING Phase EARLY_PHASE1
NCT02618590 A Retrospective Study About Treatment Strategy After First/Second Line EGFR-TKI Failure Status UNKNOWN Phase N/A